← Back to Search

Digital Education Group for Head and Neck Cancers

N/A
Waitlist Available
Led By Eitan Prisman, MD, FRCSC
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from date of surgery until the date of discharge. the number of days patients will remain in hospital after surgery can range from 7-14 days.
Awards & highlights

Study Summary

Head and neck cancer is a disease that has a particular propensity for treatment-related morbidity. It is hypothesized that patients who are more involved in their care in hospital and who are actively provided with more treatment-related education may report increased satisfaction and have improved overall outcomes. The investigators aim to determine whether delivery of patient-centred education in a multimedia format via a digital platform has an impact on overall satisfaction and perceived quality of medical care.

Eligible Conditions
  • Head and Neck Cancers

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from date of surgery until the date of discharge. the number of days patients will remain in hospital after surgery can range from 7-14 days.
This trial's timeline: 3 weeks for screening, Varies for treatment, and from date of surgery until the date of discharge. the number of days patients will remain in hospital after surgery can range from 7-14 days. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Patient Satisfaction
Secondary outcome measures
Perceived quality of medical care

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Digital Education GroupExperimental Treatment1 Intervention
In addition to the standard of care, this group will complete an audiovisual digital education module during their postoperative stay in hospital.
Group II: Control GroupActive Control1 Intervention
This group will continue to receive the routine standard of care during their treatment journey.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Digital Education Group
2021
N/A
~90

Find a Location

Who is running the clinical trial?

University of British ColumbiaLead Sponsor
1,418 Previous Clinical Trials
2,467,083 Total Patients Enrolled
Eitan Prisman, MD, FRCSCPrincipal InvestigatorUniversity of British Columbia

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Digital Patient Education Platform in Head and Neck Cancer
Eitan Prisman 2019. "Digital Patient Education Platform in Head and Neck Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05211778.
~6 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top